Archives for February 14, 2005

← 2005

Herbalife halts sale of digestion product in Israel

Leading supplements distributor Herbalife said yesterday that it had stopped selling one of its products in Israel after an investigation by health officials over complaints that it caused liver problems.

FDA delays again on lycopene/cancer decision

The FDA has requested a second extension on giving a decision on American Longevity's health claim petition on the link between lycopene and a reduced risk of developing certain types of cancer, until 12 April.

Nutra businesses sought after as M&A surges

Strong demand for thriving health foods and supplements businesses is putting sellers in a strong negotiating position, according to a report that is due to be published this month by investment bank Health Business Partners (HBP).